Citation Impact
Citing Papers
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
2017 Standout
Bone Disease after Renal Transplantation
2006
Relationship of Phosphorus and Calcium-Phosphorus Product With Mortality in CKD
2005
Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients
2007
The fallacy of the calcium-phosphorus product
2007
Progression of Coronary Artery Calcification in Predialysis Patients
2007
Mechanisms of Vascular Calcification
2007
Oral Phosphate Binders in Patients with Kidney Failure
2010
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
A Randomized Crossover Trial Comparing Sevelamer With Calcium Acetate in Children With CKD
2006
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
2008 Standout
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis
2005
Vascular Calcification
2009
Anemia and left ventricular hypertrophy in chronic kidney disease populations: A review of the current state of knowledge
2002
Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease
2010 Standout
Vascular calcifications as a marker of increased cardiovascular risk: A meta-analysis
2009 Standout
Cardiorenal Syndrome
2008 Standout
Presence of Abdominal Aortic Calcification Is Significantly Associated With All-Cause and Cardiovascular Mortality in Maintenance Hemodialysis Patients
2007
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients
2007
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients
2007
Biomarkers of inflammation and progression of chronickidney disease
2005
Coronary calcification in hemodialysis patients: The contribution of traditional and uremia-related risk factors
2005
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006 Standout
Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density
2005
Vitamin D and its analogues: Do they protect against cardiovascular disease in patients with kidney disease?
2005
Role of Hyperphosphatemia and 1,25-Dihydroxyvitamin D in Vascular Calcification and Mortality in Fibroblastic Growth Factor 23 Null Mice
2007
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 Standout
Phosphate Binder Impact on Bone Remodeling and Coronary Calcification – Results from the BRiC Study
2008
Aortic calcification in haemodialysis patients with diabetes mellitus
2005
Chronic Kidney Disease
2016 Standout
Cognitive function in Stage 5 chronic kidney disease patients on hemodialysis: No adverse effects of lanthanum carbonate compared with standard phosphate-binder therapy
2006
Calcification of Coronary Intima and Media
2006
Bioelectrical impedance analysis?part I: review of principles and methods
2004 Standout
A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care
2008 Standout
In-House Nucleic Acid Amplification Assays in Research: How Much Quality Control Is Needed before One Can Rely upon the Results?
2005
Bone Markers Predict Cardiovascular Events in Chronic Kidney Disease
2008
A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate
2007
The Tumor Lysis Syndrome
2011 Standout
Tacrolimus
2000
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Influence of the Discretization Methods on the Distribution of Relaxation Times Deconvolution: Implementing Radial Basis Functions with DRTtools
2015 Standout
Vitamin D and Immune Function
2013 Standout
Calcium Phosphate Bioceramics: A Review of Their History, Structure, Properties, Coating Technologies and Biomedical Applications
2017 Standout
Quantitation of Cytomegalovirus: Methodologic Aspects and Clinical Applications
1998
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Vascular Calcification
2006 Standout
Vascular Calcification
2008 Standout
The Vascular Endothelium and Human Diseases
2013 Standout
Low Bone Mineral Density and Fractures in Long-Term Hemodialysis Patients: A Meta-Analysis
2007
Role of Renal Angiotensin II Type 1 Receptors in the Genesis of Hypertension
2007 StandoutNobel
Works of H. Hölzer being referenced
Serum levels of the soluble receptor for tumor necrosis factor in patients with renal disease
1994
Long-term comparison of a calcium-free phosphate binder and calcium carbonate - phosphorus metabolism and cardiovascular calcification
2004
Influence of ionic shifts during dialysis on volume estimations with multifrequency impedance analysis
1997
FK 506 and Successful Pregnancy in a Patient After Renal Transplantation
1998
High prevalence of Chlamydia pneumoniae infection in cyclosporin A-induced post-transplant gingival overgrowth tissue and evidence for the possibility of persistent infection despite short-term treatment with azithromycin
2004
A RAPID IMMUNOCYTOCHEMICAL ASSAY FOR CMV DETECTION IN PERIPHERAL BLOOD OF ORGAN-TRANSPLANTED PATIENTS IN CLINICAL PRACTICE
1993
Determinants of progressive vascular calcification in haemodialysis patients
2004
Increased red cell 2,3-diphosphoglycerate levels in haemodialysis patients treated with erythropoietin
1993
Increased red cell 2,3-diphosphoglycerate levels in haemodialysis patients treated with erythropoietin.
1993